Translating promising clinical discoveries into effective therapies presents a formidable challenge. This complex process is often plagued by roadblocks, ranging from underlying biological complexities to regulatory hurdles. Bridging this gap requires a multifaceted approach that encompasses rigorous preclinical research, collaborative partnerships